This fund supports cutting-edge research in the areas of non-Hodgkin’s lymphoma, Hodgkin’s disease, acute and chronic leukemias, myelodysplastic syndromes and multiple myeloma, among other related diseases.

Funds will also be used to support obtaining excess blood, biopsy, or bone marrow cells that contain lymphoma for genomic testing and to isolate possible lymphoma targets for new treatments. The tissue bank from the Nebraska Lymphoma Study Group has supported clinical and basic research projects for over 35 years.